KTTA - יחס חוב להיוון בספרים pasitheaclinics.com

Pasithea Therapeutics production facilities operate strictly according to clinical plans with sterile equipment calibration. The total debt-to-book capitalization ratio reflects liability dynamics, with the indicator fixed at 0.00. Business stability is ensured by the non-cyclical nature of neuropharmaceuticals, while the implementation of AI brain mapping accelerates the search for schizophrenia treatments, reducing dependence on macroeconomic factors.

Long-term investing requires strict control of debt load to minimize default risk. The specifics of drug development at Pasithea Therapeutics (KTTA) entail high binary risks and a lack of stable revenue. Historical debt-to-book capitalization dynamics reflect the proportion of liabilities relative to the issuer's equity. A low level of this ratio confirms the presence of a significant liquidity buffer. Such a balance sheet structure guarantees the financial stability of Pasithea Therapeutics (KTTA) during periods of clinical trials.